These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

444 related articles for article (PubMed ID: 14502659)

  • 21. Clinical predictors of response to Acetyl Cholinesterase Inhibitors: experience from routine clinical use in Newcastle.
    Pakrasi S; Mukaetova-Ladinska EB; McKeith IG; O'Brien JT
    Int J Geriatr Psychiatry; 2003 Oct; 18(10):879-86. PubMed ID: 14533120
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Visual hallucinations and altered visual information processing in Parkinson disease and dementia with Lewy bodies.
    Kurita A; Murakami M; Takagi S; Matsushima M; Suzuki M
    Mov Disord; 2010 Jan; 25(2):167-71. PubMed ID: 20063433
    [TBL] [Abstract][Full Text] [Related]  

  • 23. How to diagnose dementia with Lewy bodies: state of the art.
    Geser F; Wenning GK; Poewe W; McKeith I
    Mov Disord; 2005 Aug; 20 Suppl 12():S11-20. PubMed ID: 16092075
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Neuropathology of Parkinson's disease dementia and dementia with Lewy bodies with reference to striatal pathology.
    Tsuboi Y; Uchikado H; Dickson DW
    Parkinsonism Relat Disord; 2007; 13 Suppl 3():S221-4. PubMed ID: 18267239
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Memantine in patients with Parkinson's disease dementia or dementia with Lewy bodies: a double-blind, placebo-controlled, multicentre trial.
    Aarsland D; Ballard C; Walker Z; Bostrom F; Alves G; Kossakowski K; Leroi I; Pozo-Rodriguez F; Minthon L; Londos E
    Lancet Neurol; 2009 Jul; 8(7):613-8. PubMed ID: 19520613
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Temporal lobe atrophy on MRI in Parkinson disease with dementia: a comparison with Alzheimer disease and dementia with Lewy bodies.
    Tam CW; Burton EJ; McKeith IG; Burn DJ; O'Brien JT
    Neurology; 2005 Mar; 64(5):861-5. PubMed ID: 15753423
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Are dementia with Lewy bodies and Parkinson's disease dementia the same disease?
    Jellinger KA; Korczyn AD
    BMC Med; 2018 Mar; 16(1):34. PubMed ID: 29510692
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Frontal and associative visual areas related to visual hallucinations in dementia with Lewy bodies and Parkinson's disease with dementia.
    Sanchez-Castaneda C; Rene R; Ramirez-Ruiz B; Campdelacreu J; Gascon J; Falcon C; Calopa M; Jauma S; Juncadella M; Junque C
    Mov Disord; 2010 Apr; 25(5):615-22. PubMed ID: 20175186
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cardiac safety of rivastigmine in Lewy body and Parkinson's disease dementias.
    Ballard C; Lane R; Barone P; Ferrara R; Tekin S
    Int J Clin Pract; 2006 Jun; 60(6):639-45. PubMed ID: 16805745
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Dementia with Lewy bodies. Review of diagnosis and pharmacologic management.
    Frank C
    Can Fam Physician; 2003 Oct; 49():1304-11. PubMed ID: 14594099
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Diagnosis and treatment of Lewy body dementia].
    Madsen AM; Lomholt RK; Djernes JK
    Ugeskr Laeger; 2002 Apr; 164(18):2383-6. PubMed ID: 12024840
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Efficacy and safety of galantamine in patients with dementia with Lewy bodies: a 24-week open-label study.
    Edwards K; Royall D; Hershey L; Lichter D; Hake A; Farlow M; Pasquier F; Johnson S
    Dement Geriatr Cogn Disord; 2007; 23(6):401-5. PubMed ID: 17409748
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Lewy body and parkinsonian dementia: common, but often misdiagnosed conditions.
    Mollenhauer B; Förstl H; Deuschl G; Storch A; Oertel W; Trenkwalder C
    Dtsch Arztebl Int; 2010 Oct; 107(39):684-91. PubMed ID: 20963199
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Dementia with Lewy bodies and Parkinson's disease with dementia: are they different?
    Tsuboi Y; Dickson DW
    Parkinsonism Relat Disord; 2005 Jun; 11 Suppl 1():S47-51. PubMed ID: 15885629
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cerebral atrophy in Parkinson's disease with and without dementia: a comparison with Alzheimer's disease, dementia with Lewy bodies and controls.
    Burton EJ; McKeith IG; Burn DJ; Williams ED; O'Brien JT
    Brain; 2004 Apr; 127(Pt 4):791-800. PubMed ID: 14749292
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cognitive profiles of individual patients with Parkinson's disease and dementia: comparison with dementia with lewy bodies and Alzheimer's disease.
    Janvin CC; Larsen JP; Salmon DP; Galasko D; Hugdahl K; Aarsland D
    Mov Disord; 2006 Mar; 21(3):337-42. PubMed ID: 16211595
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cholinesterase inhibitors in the treatment of Alzheimer's disease and related dementias.
    Masterman D
    Clin Geriatr Med; 2004 Feb; 20(1):59-68. PubMed ID: 15062487
    [No Abstract]   [Full Text] [Related]  

  • 38. Cognitive impairment in Parkinson's disease and dementia with Lewy bodies.
    Aarsland D
    Parkinsonism Relat Disord; 2016 Jan; 22 Suppl 1():S144-8. PubMed ID: 26411499
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pathological substrate of dementia in Parkinson's disease--its relation to DLB and DLBD.
    Mori H
    Parkinsonism Relat Disord; 2005 Jun; 11 Suppl 1():S41-5. PubMed ID: 15885628
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cognitive, psychiatric and motor response to galantamine in Parkinson's disease with dementia.
    Aarsland D; Hutchinson M; Larsen JP
    Int J Geriatr Psychiatry; 2003 Oct; 18(10):937-41. PubMed ID: 14533126
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 23.